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(CINIMA) and 3) Netherlands Reference Laboratory for Bacterial Meningitis, Academic Medical Centre, Amsterdam, The NetherlandsAbstractWe describe the incidence and patient characteristics of Streptococcus gallolyticus meningitis. We identiﬁed S. gallolyticus meningitis in a
nationwide cohort of patients with community-acquired bacterial meningitis, and performed a systematic review and meta-analysis of all
reported adult cases in the literature. Five cases were identiﬁed (0.3%) in a cohort of 1561 episodes of bacterial meningitis. In one
patient, bowel disease (colon polyps) was identiﬁed as a predisposing condition for S. gallolyticus infection, whereas no patients were
diagnosed with endocarditis. In a combined analysis of our patients and 37 reported in the literature, we found that the median age was
59 years. Predisposing factors were present in 21 of 42 patients (50%), and mainly consisted of immunosuppressive therapy (seven
patients), cancer (four patients), and alcoholism (four patients). Colon disease was identiﬁed in 15 of 24 patients (63%) and endocarditis
in ﬁve of 27 patients (18%). Co-infection with Strongyloides stercoralis was identiﬁed in 14 of 34 patients (41%), ten of whom were
infected with human immunodeﬁciency virus or human T-lymphotropic virus. Outcomes were described for 37 patients; eight died (22%)
and one (3%) had neurological sequelae. S. gallolyticus is an uncommon cause of bacterial meningitis, with speciﬁc predisposing conditions.
When it is identiﬁed, consultation with a cardiologist and gastroenterologist is warranted to rule out underlying endocarditis or colon
disease. Stool examinations for Strongyloides stercoralis should be performed in patients who have travelled to or originate from endemic areas.
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E-mail: d.vandebeek@amc.uva.nlIntroductionBacterial meningitis is usually caused by Streptococcus pneumoniae
and Neisseria meningitidis [1]. These bacteria form part of the
normal human nasopharyngeal ﬂora, and can cause meningitis in
both immunocompromised andhealthy individuals.Other bacteria
causing meningitis are commonly associated with speciﬁc risk
factors, such as Listeriamonocytogenes and Staphylococcus aureus [2].Clinical Microbiology and Infection © 2015 European Society of CStreptococcus gallolyticus, formerly known as a member of the
Streptococcus bovis group, is a bacterium that has been reported
to cause meningitis and endocarditis [3,4]. Three subspecies of
S. gallolyticus are known: gallolyticus, macedonicus, and pasteur-
ianus [5]. The bacteria were ﬁrst discovered in cattle, and have
been reported to be colonic commensals in 10–15% of healthy
humans [6]. Among patients with S. gallolyticus bacteraemia,
50–70% have been reported to have colon carcinoma or
benign colon abnormalities, such as diverticulosis and colon
adenomas [5,7]. S. gallolyticus infection is also associated with
strongyloidiasis, for which different hypotheses have been
suggested: (a) Strongyloides stercoralis makes the bowel wall
more permeable to bacteria such as S. gallolyticus, which can
invade the body and cause sepsis and/or meningitis; and (b) the
migrating Strongyloides larvae penetrate the gut mucosa andClin Microbiol Infect 2015; 21: 1077–1083
linical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved
http://dx.doi.org/10.1016/j.cmi.2015.08.003
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[8,9]. The incidence and patient characteristics of S. gallolyticus
meningitis are unknown.
We describe ﬁve cases of bacterial meningitis caused by
S. gallolyticus identiﬁed in a prospective nationwide cohort study
on community-acquired bacterial meningitis, and the results of
a systematic review of the literature. In this review, we describe
the epidemiology, clinical characteristics, risk factors and out-
comes of S. gallolyticus meningitis.Patients and methodsCase series
In a prospective observational cohort study in The
Netherlands, we included episodes of community-acquired
bacterial meningitis in adults conﬁrmed by cerebrospinal ﬂuid
(CSF) culture. The methods have been described previously
[10]. In summary, all patients were aged 16 years, and were
listed in the database of the Netherlands Reference Laboratory
for Bacterial Meningitis (NRLBM) from January 2006 to
December 2014. This laboratory receives CSF isolates from
approximately 90% of all patients with bacterial meningitis in
The Netherlands. The NRLBM provided daily updates of the
names of the hospitals to which patients with bacterial men-
ingitis had been admitted in the preceding 2–6 days and the
names of physicians. Physicians were contacted, and informed
consent was obtained from all participating patients or their
legally authorized representatives. Physicians could also contact
the investigators without a report by the NRLBM for inclusion
of patients.
Episodes with negative CSF cultures could also be included if
the following criteria were present: (a) blood cultures showed
S. gallolyticus; (b) CSF analysis showed at least one individual
predictor of bacterial meningitis, deﬁned as a glucose level of
<34 mg/dL (1.9 mmol/L), a CSF glucose/blood glucose ratio of
<0.23, a protein level of >220 mg/dL, or a leukocyte count of
>2000/mL [1]; and (c) the clinical presentation was compatible
with bacterial meningitis.
All patients with S. gallolyticus meningitis were selected from
this cohort. S. gallolyticus subspecies were identiﬁed with VITEK
2 (BioMérieux, Marcy-l’Etoile, France). S. gallolyticus subspecies
of cases 2 and 4 were identiﬁed with an in-house-developed
molecular biological technique sequencing a part of the gene
encoding ribosomal protein S2 (rpsB). The primers targeting
rpsB were Str_F4 (30-ATGGCAGTAATTTCAATG-50) and
Str_R2 (30-GAATTTTTCAAGACG-50). Sequences of the
amplicon were clustered with reference sequences obtained
from GenBank by use of the neighbour-joining algorithm in
MEGA 6.06 with 1000 bootstraps.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectPatients with hospital-associated meningitis, with a neuro-
surgical device or who had undergone a neurosurgical opera-
tion within 1 month before bacterial meningitis onset were
excluded. Patients using immunosuppressive drugs, with asple-
nia, with diabetes mellitus, with alcoholism or with infection
with human immunodeﬁciency virus (HIV) were considered to
be immunocompromised [10]. Additional clinical data on spe-
ciﬁc risk factors, i.e. colon disease and endocarditis, were
retrospectively collected from the discharge letters. At
discharge, all patients underwent a neurological examination
performed by a neurologist. The study was approved by the
ethics committee of the Academic Medical Centre, Amsterdam,
The Netherlands.
Review of the literature
We performed a literature search in PubMed with the terms
‘Streptococcus bovis AND meningitis’, ‘Streptococcus gallolyticus
AND meningitis’, and ‘Streptococcus caprinus AND meningitis’.
S. gallolyticus meningitis was deﬁned as described in ‘Case se-
ries’. Articles reporting on children or animals, duplicate arti-
cles and articles in which no speciﬁc data were given for
S. gallolyticus meningitis patients (e.g. articles in which there was
only an analysis of the whole group, and no subanalysis for
S. gallolyticus) were excluded. Articles with neither an abstract
nor access to the full text were excluded. Studies written in
English, German, French, Dutch, Spanish, Italian and Portuguese
were included. In a meta-analysis of clinical data, we system-
atically scored baseline and presenting characteristics (including
predisposing conditions), clinical course, and outcome.ResultsWe identiﬁed ﬁve cases of S. gallolyticus meningitis among 1561
episodes (0.32%) included in our cohort study (Table 1, Fig. S1).
The median age of the patients was 77 years (range, 50–91
years). Three patients were immunocompromised (Table 1).
All patients presented with fever and neck stiffness, and head-
ache was reported in three. Blood cultures were positive in all
patients, and CSF cultures were positive in three patients. None
of the patients was diagnosed with endocarditis, although two
died quickly before this had been investigated, and echocardi-
ography results were not known for one other patient. Colo-
noscopy was reported in two patients, and showed colon
polyps in one. Two patients died from the meningitis, and three
patients recovered without sequelae.
Case 1
A 74-year-old man presented with fever and confusion after a
holiday in Thailand. His medical history revealed chronicious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
TABLE 1. Clinical characteristics, aetiology, laboratory ﬁndings, treatment and clinical outcome for ﬁve adults with Streptococcus
gallolyticus meningitis
Characteristics Patient 1 Patient 2 Patient 3 Patient 4 Patient 5
Age (years) 74 91 77 50 84
Gender Male Female Male Male Female
Predisposing factor(s) Leukaemia None Immunosuppressants, renal failure None Diabetes
Clinical presentation
Temperature (°C) 40.0 38.5 40.4 39.2 39.7
Neck stiffness Yes Yes Yes Yes Yes
Headache Unknown Yes Unknown Yes Yes
Score on Glasgow Coma Scale 14 9 3 15 14
Neurological deﬁcits Disorientation Aphasia Right-sided hemiparesis None Disorientation
CSF ﬁndings
Leukocyte count/mm3 2880 2896 36 300 6780 2280
Protein level (g/L) 2.16 8.5 5.6 Unknown 7.6
CSF/blood glucose ratio 0.40 0.23 0.30 0.32 0.36
Cranial CT Normal Normal Infarction in left cerebral hemisphere Normal Normal
Cultures
Blood culture Positive Positive Positive Positive Positive
CSF culture Negative Negative Positive Positive Positive
S. gallolyticus-associated disease
Endocarditis Unknown Unknown Unknown No No
Bowel abnormalities Unknown Unknown Unknown Normal Colon polyps
Empirical treatment
Antibiotics Amoxycillin, ceftriaxone Amoxycillin, cefotaxime Penicillin Ceftriaxone Penicillin
Dexamethasone Yes Yes Yes Yes Yes
Outcome Recovery Death Death Recovery Recovery
CSF, cerebrospinal ﬂuid; CT, computed tomography.
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bladder. Physical examination showed fever, disorientation, and
neck stiffness. CSF examination was consistent with bacterial
meningitis (Table 1). Blood cultures were positive for
S. gallolyticus; CSF cultures were negative. Amoxycillin 2 g six
times daily, ceftriaxone 2 g twice daily and dexamethasone
10 mg four times daily were started. The patient was discharged
after 11 days. Investigations for endocarditis, colon disease and
strongyloidiasis were not performed.
Case 2
A 91-year-old woman presented with headache, vomiting, and
aphasia. Her medical history revealed hypertension, anaemia,
and atrial ﬁbrillation, for which she used antihypertensives and
acenocoumarol. Physical examination showed fever, neck stiff-
ness, and aphasia. After correction of the coagulation status,
lumbar puncture was performed, and showed CSF abnormal-
ities consistent with meningitis (Table 1). The patient was
treated with amoxycillin 2 g six times daily, cefotaxime 2 g six
times daily, and dexamethasone 10 mg four times daily. She died
1 day after admission. Blood cultures became positive for
S. gallolyticus ssp. gallolyticus (Fig. S1); CSF cultures were
negative.
Case 3
A 77-year-old man with a medical history including haemo-
dialysis for renal failure presented with fever. Physical exami-
nation showed neck stiffness and a right-sided hemiparesis.
Cranial computed tomography showed a hypodensityClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology anconsistent with left-hemisphere cerebral infarction. CSF ex-
amination was consistent with bacterial meningitis (Table 1).
The patient was treated with penicillin 6 MU six times daily and
dexamethasone 10 g four times daily. He developed respiratory
failure and died on the same day. Blood and CSF cultures were
positive for S. gallolyticus.
Case 4
A 50-year-old man complained of fever and progressive head-
ache lasting for 3 days. His medical history showed no abnor-
malities. Physical examination showed fever and neck stiffness.
CSF examination was consistent with bacterial meningitis
(Table 1). Treatment with ceftriaxone 2 g twice daily and
dexamethasone 10 mg four times daily was started. S. gallolyticus
ssp. pasteurianus (Fig. S1) was cultured from CSF and blood.
Transthoracic ultrasound and colonoscopy did not show
endocarditis or colon abnormalities. The patient was discharged
after 11 days in good clinical condition.
Case 5
An 84-year-old woman presented with headache and confusion.
Her medical history showed atrial ﬁbrillation, diabetes, and
heart failure. Physical examination showed disorientation and
no neck stiffness. CSF examination was consistent with bacterial
meningitis (Table 1). Empirical treatment was started with
amoxycillin 2 g six times daily, ceftriaxone 2 g daily, and
dexamethasone 10 mg four times daily. S. gallolyticus was
cultured from blood and CSF, and antibiotic treatment was
switched to penicillin 2 MU six times daily. Transthoracicd Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
1080 Clinical Microbiology and Infection, Volume 21 Number 12, December 2015 CMIultrasound did not show endocarditis; colonoscopy showed
colon polyps. The patient was discharged after 19 days in good
clinical condition.
Review of the literature
In total, 86 studies were identiﬁed, of which 28 met the in-
clusion criteria, describing 37 patients (Fig. 1). The identiﬁed
studies were performed between 1975 and 2015 (Table S1,
Supplementary reference list).
Combining these data with those of our patients (Table 2),
we found that the median age was 59 years, and that 27 of 41
patients (66%) were male. Predisposing factors were described
for 18 of 42 patients (43%), and mainly consisted of immuno-
suppressive therapy (seven patients), cancer (four patients), and
alcoholism (four patients) (Table 2). Three patients had an
anatomical defect (CSF leak, ventriculostomy, and postoperative
cystic cavity communicating with the intradural space). Fourteen
patients suffered from strongyloidiasis, and in 13 the strongy-
loidiasis infection was associated with an underlying disease
(human T-lymphotropic virus (HTLV)-1 infection in eight, HIV
infection in two, and immunosuppressive medication in three).86 articles assessed for eligibility
- 82 literature search
-   4 cross-checking references  
54 articles included
32 articles not meeting in
- 27 children
-  5 animals   
28 articles used in review
- 15 European studies
- 10 Asian studies
-   3 American studies   
26 articles excluded from
- 11 no S. gallolyticus me
-   6 no abstract nor full a
-   3 non-western Europea
-   3 duplicate articles
-   3 no subanalysis possib
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectPresenting symptoms were reported for 31 patients
(Table 2). Colon abnormalities were identiﬁed in 15 of 24
patients (63%): diverticulosis (ﬁve patients), colon adenoma
(ﬁve patients), colon carcinoma (two patients), and ulcers,
radiation enterocolitis, and radiation proctitis (each in one
patient). Endocarditis was diagnosed in ﬁve of 28 patients
(18%). One patient had both colonic diverticulosis and
endocarditis.
CSF cultures were positive in 36 of 41 patients (88%), and
blood cultures were positive in 33 of 38 patients (87%)
(Table 1). For nine patients, the subspecies of S. gallolyticus was
reported; eight were S. gallolyticus ssp. pasteurianus [11–17].
Fourteen of 42 patients (33%) received adjuvant treatment
with dexamethasone. Complications of S. gallolyticus meningitis
were reported in eight of 36 patients (22%), and consisted of
atrial ﬁbrillation, respiratory insufﬁciency, pneumonia, hearing
loss, transient facial nerve paralysis, seizures, hyponatraemia,
and progression despite treatment, occurring in one patient
each.
Eight of 37 patients died (22%) and three survivors (10%) had
sequelae, consisting of hearing loss in one patient and persistingclusion criteria
 review
ningitis case
rticle available
n language
le
FIG. 1. Flow chart of review of articles on
Streptococcus gallolyticus meningitis.
ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
TABLE 2. Clinical characteristics, aetiology and clinical
outcome for adults with Streptococcus gallolyticus meningitis;
combination of our patients and patients described in the
literature
Characteristics Value
Median age (years), range 59 (23–91)
Male, n/N (%) 27/41 (66)
Predisposing factor(s), n/N (%) 18/42 (43)
Immunosuppressants, n (%) 7 (17)
Cancer, n (%) 4 (10)
Alcoholism, n (%) 4 (10)
HIV infection, n (%) 3 (7)
Diabetes mellitus, n (%) 3 (7)
Renal failure, n (%) 2 (7)
Splenectomy, n (%) 1 (2)
Clinical presentation, n/N (%)
Headache 21/31 (68)
Fever 26/31 (84)
Neck stiffness 20/31 (65)
Altered consciousness 13/31 (42)
Nausea 6/31 (19)
Photophobia 6/31 (19)
S. gallolyticus-associated disease, n/N (%)
Strongyloidiasis 14/34 (41)
Endocarditis 5/28 (18)
Colon abnormalities 15/24 (63)
Positive cultures, n/N (%)
Blood 33/38 (87)
Cerebrospinal ﬂuid 36/41 (88)
Both 27/37 (43)
Complications, n/N (%) 8/36 (22)
Outcome, n/N (%)
Death 8/37 (22)
Sequelae 3/29 (10)
Full recovery 26/29 (90)
HIV, human immunodeﬁciency virus.
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gyloidiasis, and the nausea disappeared after treatment.DiscussionS. gallolyticus is a rare cause of community-acquired bacterial
meningitis. Only ﬁve of 1561 patients in our cohort (0.3%) were
infected with S. gallolyticus. In the literature, cases of
S. gallolyticus meningitis have been described in cohorts of pa-
tients with speciﬁc risk factors. In a cohort of patients with
bacterial meningitis and liver cirrhosis, one of 12 patients had
S. gallolyticus meningitis, and in a case series of patients with
bacterial meningitis and coexisting strongyloidiasis, one of six
patients had S. gallolyticus meningitis [18,19]. In two cohorts of
patients with streptococcal meningitis, the relative incidence
rates of S. gallolyticus meningitis were one in 26 cases and one in
29 cases [20,21].
Risk factors for S. gallolyticus meningitis are endocarditis [3]
and colon disease [5,7]. S. gallolyticus infection is the cause of
2–10% of cases of bacterial endocarditis, and is associated with
advanced age as compared with bacterial endocarditis caused by
other pathogens [22]. Endocarditis has been reported to be
caused by S. gallolyticus ssp. gallolyticus more frequently than by
S. gallolyticus ssp. pasteurianus—reported rates vary betweenClinical Microbiology and Infection © 2015 European Society of Clinical Microbiology an43% and 100%, as compared with rates of 8–29% [23,24]. In our
study, one patient was infected with S. gallolyticus ssp. pasteur-
ianus, and none of the patients was diagnosed with endocarditis.
The rate of endocarditis could have been under-reported,
because only two patients underwent echocardiography. In
our meta-analysis, ﬁve of 28 patients were diagnosed with
endocarditis, and colonoscopy ﬁndings were abnormal in 15 of
24 patients. When S. gallolyticus is identiﬁed in patients with
bacterial meningitis, consultation with a gastroenterologist and
cardiologist is warranted to identify whether a colonic disease or
endocarditis is present as a risk factor for S. gallolyticusmeningitis,
in most cases by colonoscopy and echocardiography [25].
Strongyloidiasis has been described as a risk factor for
S. gallolyticus meningitis [18,26]. This is due to increased perme-
ability of the bowel wall, through which S. gallolyticus can invade
the bloodstream and thus cause sepsis and meningitis. In endemic
areas such as Brazil and Thailand, Strongyloides stercoralis infection
has an estimated prevalence of 10–40% [27]. One of our patients
had visited Thailand prior to developing S. gallolyticus meningitis,
where he could have been infected with Strongyloides stercoralis.
Strongyloidiasis has been described as a disease imported by
travellers to endemic areas even 60 years after travel [27]. In our
patient, no stool examination was performed to detect Strong-
yloides stercoralis. So far, all patients with S. gallolyticus meningitis
due to Strongyloides stercoralis infection reported in the literature
have lived in an endemic area, and imported cases have not been
described. Strongyloidiasis may cause mild gastrointestinal
symptoms such as diarrhoea, pulmonary symptoms, or no
symptoms at all, and may therefore go unnoticed. High-risk
groups for Strongyloides stercoralis infection are alcoholics, HIV-
infected and HTLV-1-infected persons, cancer patients, and
other patients who are immunocompromised. All but one of the
patients with strongyloidiasis in our meta-analysis were immu-
nocompromised. It has previously been reported that immuno-
compromised patients with strongyloidiasis are prone to
meningitis or sepsis with enteric organisms [28]. Testing for
Strongyloides stercoralis and (if positive) HIV testing should be
performed in patients with S. gallolyticus meningitis who have
travelled to or originate from areas endemic for strongyloidiasis.
Our study has several limitations. As this is an observational
cohort study, patients did not undergo diagnostic procedures
or testing according to a prespeciﬁed protocol. Therefore, the
patients were not routinely tested for HIV, HTLV-1, and
strongyloidiasis, and colonoscopy and echocardiography were
not performed in all patients; risk factors for S. gallolyticus
meningitis could therefore have been missed. Furthermore, not
all patients with suspected bacterial meningitis may undergo a
lumbar puncture, e.g. patients with coagulopathy due to sepsis
or those with space-occupying lesions on cranial imaging. These
patients were not included in our cohort, which may have ledd Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
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meningitis. In our meta-analysis, it was often the case that not all
characteristics of interest were reported in the retrieved case
reports. Therefore, we have presented the total number of
patients for whom the speciﬁc characteristic was reported.
Furthermore, there are inherent difﬁculties in identifying
S. gallolyticus accurately to the subspecies level, in particular
because of the use of multiple methods for identiﬁcation,
changing nomenclature, and the wide variations in time and
geographical regions analysed.
We conclude that S. gallolyticus is a rare cause of bacterial
meningitis. When it is identiﬁed, consultation with a gastroen-
terologist and cardiologist is warranted, to identify whether a
concomitant colon disease or endocarditis is present. Stool
examinations for Strongyloides stercoralis should be performed in
patients who have travelled to or originate from endemic areas.Transparency declarationThe authors report no conﬂicts of interests.AcknowledgementsM. C. Brouwer is supported by a grant from the Netherlands
Organization for Health Research and Development (ZonMw;
NWO-Veni grant 2012 (916.13.078)). D. van de Beek is sup-
ported by grants from the Netherlands Organization for Health
Research and Development (ZonMw; NWO-Vidi grant 2010
(016.116.358)), and the European Research Council (ERC
Starting Grant 281156).Appendix A. Supplementary dataSupplementary data related to this article can be found at http://
dx.doi.org/10.1016/j.cmi.2015.08.003.References[1] van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB,
Vermeulen M. Clinical features and prognostic factors in adults with
bacterial meningitis. N Engl J Med 2004;351:1849–59.
[2] Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and
antimicrobial treatment of acute bacterial meningitis. Clin Microbiol
Rev 2010;23:467–92.
[3] Mello R, da Silva Santos M, Golebiosvki W, Weksler C, Lamas C.
Streptococcus bovis endocarditis: analysis of cases between 2005 and
2014. Braz J Infect Dis 2015;19:209–12.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect[4] Jacobson MA, Anderson ET. Streptococcus bovis meningitis. J Neurol
Neurosurg Psychiatry 1987;50:940–1.
[5] Abdulamir AS, Haﬁdh RR, Abu Bakar F. The association of Strepto-
coccus bovis/gallolyticus with colorectal tumors: the nature and the un-
derlying mechanisms of its etiological role. J Exp Clin Cancer Res
2011;30:11.
[6] Higginbottom C, Wheater DWF. The incidence of Streptococcus bovis
in cattle. J Agric Sci 1954;44:434–42.
[7] Murray HW, Roberts RB. Streptococcus bovis bacteremia and underlying
gastrointestinal disease. Arch Intern Med 1978;138:1097–9.
[8] Keiser PB, Nutman TB. Strongyloides stercoralis in the immunocom-
promised population. Clin Microbiol Rev 2004;17:208–17.
[9] Link K, Orenstein R. Bacterial complications of strongyloidiasis:
Streptococcus bovis meningitis. South Med J 1999;92:728–31.
[10] Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB,
van de Beek D. Nationwide implementation of adjunctive dexameth-
asone therapy for pneumococcal meningitis. Neurology 2010;75:
1533–9.
[11] Pukkila-Worley R. Case 28-2014: a man with a rash, headache, fever,
nausea, and photophobia. N Engl J Med 2014;371:2239.
[12] Smith AH, Sra HK, Bawa S, Stevens R. Streptococcus bovis meningitis
and hemorrhoids. J Clin Microbiol 2010;48:2654–5.
[13] Sturt AS, Yang L, Sandhu K, Pei Z, Cassai N, Blaser MJ. Streptococcus
gallolyticus subspecies pasteurianus (biotype II/2), a newly reported
cause of adult meningitis. J Clin Microbiol 2010;48:2247–9.
[14] Namiduru M, Karaoglan I, Aktaran S, Dikensoy O, Baydar I. A case of
septicaemia, meningitis and pneumonia caused by Streptococcus bovis
type II. Int J Clin Pract 2003;57:735–6.
[15] Vilarrasa N, Prats A, Pujol M, Gason A, Viladrich PF. Streptococcus bovis
meningitis in a healthy adult patient. Scand J Infect Dis 2002;34:61–2.
[16] Cohen LF, Dunbar SA, Sirbasku DM, Clarridge 3rd JE. Streptococcus
bovis infection of the central nervous system: report of two cases and
review. Clin Infect Dis 1997;25:819–23.
[17] Coret Ferrer F, Vilchez Padilla JJ, Igual Adell R, Ferrando Ginestar J.
Streptococcus bovis meningitis: no association with colonic malignancy.
Clin Infect Dis 1993;17:527–8.
[18] Sasaki Y, Taniguchi T, Kinjo M, McGill RL, McGill AT, Tsuha S, et al.
Meningitis associated with strongyloidiasis in an area endemic for
strongyloidiasis and human T-lymphotropic virus-1: a single-center
experience in Japan between 1990 and 2010. Infection 2013;41:
1189–93.
[19] Barahona-Garrido J, Hernandez-Calleros J, Tellez-Avila FI, Chávez-
Tapia NC, Remes-Troche JM, Torre A. Bacterial meningitis in cirrhotic
patients: case series and description of the prognostic role of acute
renal failure. J Clin Gastroenterol 2010;44:e218–23.
[20] Moller K, Frederiksen EH, Wandall JH, Skinhoj P. Meningitis caused by
streptococci other than Streptococcus pneumoniae: a retrospective
clinical study. Scand J Infect Dis 1999;31:375–81.
[21] Cabellos C, Viladrich PF, Corredoira J, Verdaguer R, Ariza J, Gudiol F.
Streptococcal meningitis in adult patients: Current epidemiology and
clinical spectrum. Clin Infect Dis 1999;28:1104–8.
[22] Murdoch DR, Corey GR, Hoen B, Miró JM, Fowler Jr VG, Bayer AS,
et al. Clinical presentation, etiology, and outcome of infective endo-
carditis in the 21st century: the International Collaboration on
Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:
463–73.
[23] Corredoira J, Alonso MP, Coira A, Casariego E, Arias C, Alonso D,
et al. Characteristics of Streptococcus bovis endocarditis and its differ-
ences with Streptococcus viridans endocarditis. Eur J Clin Microbiol
Infect Dis 2008;27:285–91.
[24] Boleij A, van Gelder MM, Swinkels DW, Tjalsma H. Clinical impor-
tance of Streptococcus gallolyticus infection among colorectal cancer
patients: systematic review and meta-analysis. Clin Infect Dis 2011;53:
870–8.ious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
CMI van Samkar et al. Streptococcus gallolyticus meningitis in adults 1083[25] Lucas MJ, Brouwer MC, van der Ende A, van de Beek D. Endocarditis
in adults with bacterial meningitis. Circulation 2013;127:2056–62.
[26] Shimsaki T, Chung H, Shiiki S. Five cases of recurrent meningitis associ-
ated with chronic strongyloidiasis. Am J Trop Med Hyg 2015;92:601–4.
[27] Schar F, Trostdorf U, Giardina F, Khieu V, Muth S, Marti H, et al.
Strongyloides stercoralis: Global distribution and risk factors. PLoS Negl
Trop Dis 2013;7:e2288.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology an[28] Shields AM, Goderya R, Atta M, Sinha P. Strongyloides stercoralis
hyperinfection presenting as subacute small bowel obstruction
following immunosuppressive chemotherapy for multiple myeloma.
BMJ Case Rep 2014:2014.d Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 1077–1083
